Why are Medical Developments shares crashing 11% lower today?

The Medical Developments International Ltd (ASX: MVP) share price is crashing lower on a day of sharp falls across most ASX sectors.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Medical Developments International Ltd (ASX: MVP) share price is crashing lower on a day which has seen a sharp fall across most of the ASX's major sectors. 

At the time of writing, the S&P/ASX 200 Index (INDEXASX: XJO) is down 2.14% while Medical Developments shares are trading 10.9% lower at $9.58.

So, what appears to be behind this fall?

What does Medical Developments do?

Medical Developments is an Australia-based healthcare company that offers a range of open and closed circuit anaesthetic machines to the veterinary market.

In addition to veterinary equipment, the company also has a range of products in the areas of pain management, asthma and resuscitation.

What's behind today's sharp fall?

There doesn't appear to be any major company announcement or activity that has triggered today's fall.

In my view, today's fall is most likely a market correction after Medical Developments' very strong run on the ASX since September last year. This correction appears to have begun last Friday when the Medical Developments share price fell by 4.5%.

During the period from 10 September 2019 to the close of trade last Thursday, Medical Developments shares had gone up by a massive 156%.

I don't think the company's fundamentals are strong enough to continue to support such a continued high growth rate. Therefore, a market correction, triggered by the ASX's wider falls today, is not surprising.

Looking back further over the past two years, the Medical Developments share price had fallen back from the period of January 2018 until January 2019, further supporting the case for a market correction.

Strong recent financials

Medical Developments released its 1H20 results to the market last Wednesday, reporting an 82% increase in net profit after tax to $240,000. This was up from the $132,000 that it recorded in 1H19.

Meanwhile, gross revenue for the period came in at $11.2 million, up 15% from $9.8 million in the prior corresponding period. Gross margins remained strong and largely consistent with the prior year at 67%, while earnings before interest, tax, depreciation and amortisation (EBITDA) was up 21% to $1.5 million.

Foolish takeway

Today's share price falls appears to be a market correction to a strong recent run for Medical Developments on the ASX since last September.

I believe the underlying fundamentals of Medical Developments remain strong, and that the company is positioned for strong growth over the next year or two.

Phil Harpur has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Medical Developments International Limited. The Motley Fool Australia has recommended Medical Developments International Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Broker Notes

These ASX 200 shares could rise 50% to 60%

Brokers believe these shares could deliver big returns for investors.

Read more »

A girl is handed an oversized ice cream cone with lots of different flavours.
Best Shares

8 ASX All Ords shares that tripled in value in FY25

Just 8 out of the 500 companies making up the ASX All Ords achieved share price growth of 200% or…

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Woman with a scared look has hands on her face.
Broker Notes

Bapcor shares fell more than 30% yesterday. Should investors buy in the dip?

Is this a value opportunity?

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Broker Notes

Broker raises price targets on 2 ASX 200 shares to buy

Ord Minnett has just upped its 12-month share price targets on 2 buy-rated ASX 200 stocks.

Read more »

Man with rocket wings which have flames coming out of them.
Share Gainers

Guess which ASX All Ords stock just rocketed 34% on strong earnings growth

Investors just sent this ASX All Ords stock surging 34%. Here’s what’s happening.

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why DroneShield, Gentrack, Metals X, and Northern Star shares are tumbling today

These shares are ending the week in the red. But why?

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Share Gainers

Why Dimerix, Newmont, Regal Partners, and Titomic shares are storming higher

These shares are having a good finish to the week. Let's see why.

Read more »